You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

Details for New Drug Application (NDA): 021762

✉ Email this page to a colleague

« Back to Dashboard

NDA 021762 describes FOSAMAX PLUS D, which is a drug marketed by Organon Llc and is included in one NDA. It is available from one supplier. Additional details are available on the FOSAMAX PLUS D profile page.

The generic ingredient in FOSAMAX PLUS D is alendronate sodium; cholecalciferol. There are twenty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alendronate sodium; cholecalciferol profile page.

Summary for 021762

Tradename:	FOSAMAX PLUS D
Applicant:	Organon Llc
Ingredient:	alendronate sodium; cholecalciferol
Patents:	0

Pharmacology for NDA: 021762

Suppliers and Packaging for NDA: 021762

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
FOSAMAX PLUS D	alendronate sodium; cholecalciferol	TABLET;ORAL	021762	NDA	Organon LLC	78206-136	78206-136-01	4 TABLET in 1 BLISTER PACK (78206-136-01)
FOSAMAX PLUS D	alendronate sodium; cholecalciferol	TABLET;ORAL	021762	NDA	Organon LLC	78206-137	78206-137-01	4 TABLET in 1 BLISTER PACK (78206-137-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 70MG BASE;2,800 IU
Approval Date:	Apr 7, 2005	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 70MG BASE;5,600 IU
Approval Date:	Apr 26, 2007	TE:		RLD:	Yes

Expired US Patents for NDA 021762

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Organon Llc	FOSAMAX PLUS D	alendronate sodium; cholecalciferol	TABLET;ORAL	021762-002	Apr 26, 2007	5,358,941*PED	⤷ Get Started Free
Organon Llc	FOSAMAX PLUS D	alendronate sodium; cholecalciferol	TABLET;ORAL	021762-001	Apr 7, 2005	4,621,077*PED	⤷ Get Started Free
Organon Llc	FOSAMAX PLUS D	alendronate sodium; cholecalciferol	TABLET;ORAL	021762-002	Apr 26, 2007	5,681,590*PED	⤷ Get Started Free
Organon Llc	FOSAMAX PLUS D	alendronate sodium; cholecalciferol	TABLET;ORAL	021762-002	Apr 26, 2007	6,090,410*PED	⤷ Get Started Free
Organon Llc	FOSAMAX PLUS D	alendronate sodium; cholecalciferol	TABLET;ORAL	021762-002	Apr 26, 2007	4,621,077*PED	⤷ Get Started Free
Organon Llc	FOSAMAX PLUS D	alendronate sodium; cholecalciferol	TABLET;ORAL	021762-001	Apr 7, 2005	5,994,329*PED	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.